Lataa...
Targeting MLL1 H3 K4 methyltransferase activity in MLL leukemia
Here we report a comprehensive characterization of our newly developed inhibitor MM-401 that targets the MLL1 H3 lysine (K) 4 methyltransferase activity. MM-401 is able to specifically inhibit MLL1 activity by blocking MLL1-WDR5 interaction and thus the complex assembly. This novel targeting strateg...
Tallennettuna:
| Päätekijät: | , , , , , , , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3965208/ https://ncbi.nlm.nih.gov/pubmed/24389101 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molcel.2013.12.001 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|